The third edition of CAR-TCR  Europe will be held in London, UK. More than 350 attendees with diverse backgrounds, 200 plus companies, and over 60 plus world-class speakers will attend the 4 days long summit to discuss the manufacturing, delivery, safety management and commercial viability of CAR and TCR immunotherapies for liquid and solid tumours.

The key focus for the summit includes a comprehensive and complete roadmap for Translation, Discovery, Manufacturing, Logistics, Clinical Management, Commercialization opportunity of CAR-T and TCR drug.